Individualized antibiotic dosage regimens for patients with augmented renal clearance

被引:14
作者
Shi, A-Xi [1 ,2 ]
Qu, Qiang [3 ,4 ,5 ]
Zhuang, Hai-Hui [1 ]
Teng, Xin-Qi [1 ]
Xu, Wei-Xin [1 ]
Liu, Yi-Ping [1 ]
Xiao, Yi-Wen [1 ]
Qu, Jian [1 ,5 ]
机构
[1] Cent South Univ, Xiangya Hosp 2, Inst Clin Pharm, Dept Pharm, Changsha, Peoples R China
[2] First Hosp Lanzhou Univ, Dept Pharm, Lanzhou, Peoples R China
[3] Cent South Univ, Xiangya Hosp, Dept Pharm, Changsha, Peoples R China
[4] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Peoples R China
[5] Changsha Med Univ, Hunan Key Lab Res & Dev Novel Pharmaceut Preparat, Changsha, Peoples R China
关键词
augmented renal clearance; antibiotic; pharmacokinetics; pharmacodynamics; individualized; CRITICALLY-ILL PATIENTS; INFECTIOUS-DISEASES SOCIETY; STAPHYLOCOCCUS-AUREUS INFECTIONS; VITRO ANTIMICROBIAL ACTIVITY; AMOXICILLIN-CLAVULANIC ACID; MONTE-CARLO-SIMULATION; POPULATION PHARMACOKINETICS; ANTIBACTERIAL ACTIVITY; PSEUDOMONAS-AERUGINOSA; CREATININE CLEARANCE;
D O I
10.3389/fphar.2023.1137975
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives: Augmented renal clearance (ARC) is a state of enhanced renal function commonly observed in 30%-65% of critically ill patients despite normal serum creatinine levels. Using unadjusted standard dosing regimens of renally eliminated drugs in ARC patients often leads to subtherapeutic concentrations, poor clinical outcomes, and the emergence of multidrug-resistant bacteria. We summarized pharmaceutical, pharmacokinetic, and pharmacodynamic research on the definition, underlying mechanisms, and risk factors of ARC to guide individualized dosing of antibiotics and various strategies for optimizing outcomes.Methods: We searched for articles between 2010 and 2022 in the MEDLINE database about ARC patients and antibiotics and further provided individualized antibiotic dosage regimens for patients with ARC.Results: 25 antibiotic dosage regimens for patients with ARC and various strategies for optimization of outcomes, such as extended infusion time, continuous infusion, increased dosage, and combination regimens, were summarized according to previous research.Conclusion: ARC patients, especially critically ill patients, need to make individualized adjustments to antibiotics, including dose, frequency, and method of administration. Further comprehensive research is required to determine ARC staging, expand the range of recommended antibiotics, and establish individualized dosing guidelines for ARC patients.
引用
收藏
页数:14
相关论文
共 177 条
  • [1] Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
    Abdul-Aziz, Mohd H.
    Alffenaar, Jan-Willem C.
    Bassetti, Matteo
    Bracht, Hendrik
    Dimopoulos, George
    Marriott, Deborah
    Neely, Michael N.
    Paiva, Jose-Artur
    Pea, Federico
    Sjovall, Fredrik
    Timsit, Jean F.
    Udy, Andrew A.
    Wicha, Sebastian G.
    Zeitlinger, Markus
    De Waele, Jan J.
    Roberts, Jason A.
    [J]. INTENSIVE CARE MEDICINE, 2020, 46 (06) : 1127 - 1153
  • [2] Evaluation of Meropenem-Ciprofloxacin Combination Dosage Regimens for the Pharmacokinetics of Critically Ill Patients With Augmented Renal Clearance
    Agyeman, Akosua A.
    Rogers, Kate E.
    Tait, Jessica R.
    Bergen, Phillip J.
    Kirkpatrick, Carl M.
    Wallis, Steven C.
    Bulitta, Jurgen B.
    Paterson, David L.
    Lipman, Jeffrey
    Nation, Roger L.
    Roberts, Jason A.
    Landersdorfer, Cornelia B.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 (04) : 1104 - 1115
  • [3] Colistin Use in Patients with Extreme Renal Function: From Dialysis to Augmented Clearance
    Aitullina, Aleksandra
    Krumina, Angelika
    Svirskis, Simons
    Purvina, Santa
    [J]. MEDICINA-LITHUANIA, 2019, 55 (02):
  • [4] Modified Augmented Renal Clearance score predicts rapid piperacillin and tazobactam clearance in critically ill surgery and trauma patients
    Akers, Kevin S.
    Niece, Krista L.
    Chung, Kevin K.
    Cannon, Jeremy W.
    Cota, Jason M.
    Murray, Clinton K.
    [J]. JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2014, 77 : S163 - S170
  • [5] Levofloxacin - A review of its use as a high-dose, short-course treatment for bacterial infection
    Anderson, Vanessa R.
    Perry, Caroline M.
    [J]. DRUGS, 2008, 68 (04) : 535 - 565
  • [6] Population Pharmacokinetics of Amikacin Administered Once Daily in Patients with Different Renal Functions
    Arechiga-Alvarado, Norma A.
    Medellin-Garibay, Susanna E.
    Milan-Segovia, Rosa del C.
    Ortiz-Alvarez, Arturo
    Magana-Aquino, Martin
    Romano-Moreno, Silvia
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (05)
  • [7] Optimizing Aminoglycoside Dosing Regimens for Critically III Pediatric Patients with Augmented Renal Clearance: a Convergence of Parametric and Nonparametric Population Approaches
    Avedissian, Sean N.
    Rohani, Roxane
    Bradley, John
    Le, Jennifer
    Rhodes, Nathaniel J.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (04)
  • [8] Avedissian Sean N, 2020, J Pediatr Pharmacol Ther, V25, P413, DOI 10.5863/1551-6776-25.5.413
  • [9] Augmented renal clearance of aminoglycosides using population-based pharmacokinetic modelling with Bayesian estimation in the paediatric ICU
    Avedissian, Sean N.
    Rhodes, Nathaniel J.
    Kim, Yuna
    Bradley, John
    Valdez, Joshua L.
    Le, Jennifer
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (01) : 162 - 169
  • [10] Vancomycin levels are frequently subtherapeutic in critically ill patients: a prospective observational study
    Bakke, V.
    Sporsem, H.
    Von der Lippe, E.
    Nordoy, I.
    Lao, Y.
    Nyrerod, H. C.
    Sandvik, L.
    Harvig, K. R.
    Bugge, J. F.
    Helset, E.
    [J]. ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2017, 61 (06) : 627 - 635